GO
| HSI1 | 23,094.83 | 0.00 | -- |
| HSCEI1 | 7,791.63 | 0.00 | -- |
| Back Zoom + Zoom - Block Traded | |
|
BRAINAURORA-B (06681.HK) Depression Cognitive Function Assessment Software Obtains Medical Device Registration Certificate
2026-10-28 09:13:39 BRAINAURORA-B (06681.HK) announced that it has received a Class II medical device registration certificate issued by the Beijing Municipal Medical Products Administration for its cognitive function assessment software designed for patients with depression. Clinical trials for the product commenced in September 2024 and were completed in August 2025. The company said cognitive symptoms persist throughout the course of depression, affecting the efficacy and cure rate of antidepressant treatments, increasing the risk of relapse, and preventing some patients from resuming normal social functions. The product is the company's first medical device registration certificate granted by the Beijing authority and also the first cognitive function assessment medical device registration certificate in the depression field. The company expects the approval to further strengthen its digital medical product portfolio for cognitive disorders. (gc/j)~ AASTOCKS Financial News Website: www.aastocks.com This article was automatically translated by AI, the Chinese version should be considered the authoritative version. AASTOCKS.com Limited does not guarantee its accuracy or completeness and accepts no liability for any damages or losses arising from the use of this translation. | |